To study the impact of prehospital management duration by SMUR teams in the Essonne department (91) on early patient mortality (within 24 hours) and to analyze the procedures performed on scene.
The study hypothesis is that all-cause in-hospital mortality may be associated with the duration of prehospital care, with either a beneficial impact related to the performance of life-saving interventions or a negative impact due to prolonged time to access definitive treatment.
Identifying potential factors associated with prolonged prehospital management times could help define possible areas for improvement and future interventions.
Eligibility
Sex
ALL
Min age
15 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
* Age ≥ 15 years (upper age limit for the pediatric population)
* Severe trauma, defined as any road traffic accident, defenestration, fall from a height greater than 3 meters, stab wound, or ballistic injury requiring medically supervised transport to one of the Level 1 trauma centers in the Île-de-France region
* Prehospital management provided by one of the SMUR teams in the Essonne department (91)
Exclusion Criteria:
* Patients declared dead at initial medical contact, without resuscitation initiated, or with resuscitation attempted and subsequently discontinued (non-return of spontaneous circulation)
* Secondary inter-hospital transfer from another hospital to a Level 1 trauma center
* Transport to a hospital for local computed tomography imaging only (without direct admission to a Level 1 trauma center)
* Cases regulated (dispatched) by emergency coordination centers other than the Essonne (91) medical dispatch center
Primary outcome measure(s)
Mortality — at day 0 All-cause in-hospital mortality within 24 hours
Trial sites (1)
Facility
City
Region
Status
Centre Hospitalier Sud Francilien
Corbeil-Essonnes
France
More Centre Hospitalier Sud Francilien trials in France
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.
